Our data provides a rationale and a novel mechanism, which includes immunity to modified self-proteins as a disease modifier, rather than autoimmunity as a primary pathological mechanism.
Please choose risk.type = 3 to include immunity in all calculations.
These mechanisms include cell cycle, immunity, inflammation, and apoptosis pathways.
These findings together with other experimental studies support a model in which B cells, through various mechanisms, including humoral immunity, activating FcγRs and IKK, are required for establishing chronic inflammatory programs that promote de novo carcinogenesis.
Other possible mechanisms include transient post-infection immunity and evolutionary changes that may occur in the characteristics of the infectious pathogens [ 2, 4, 10].
Metronomic chemotherapy using cyclophosphamide (CPA) is widely associated with antiangiogenesis; however, recent studies implicate other immune-based mechanisms, including antitumor innate immunity, which can induce major tumor regression in implanted brain tumor models.
HT has cytotoxic effects on tumor cells via several mechanisms including improved antitumor immunity (discussed later) and by direct cytotoxic effects.
Other proposed mechanisms include asthma-induced pathologic alterations that can impair clearance of pathogenic bacteria from the airway 27, 28 and chronic airway inflammation leading to impaired respiratory immunity.
These mechanisms include both cellular and soluble components and are potent enough to limit the development of durable antitumor response in patients treated with IL-12, despite induction of specific immunity against tumor-associated antigens in some patients [ 183].
Inflammation mainly involves innate immunity mechanisms including toll-like receptor activation [ 44, 68] and NFκB intracellular signaling both in local cells (cardiomyocytes, fibroblasts) and in infiltrating leukocytes [ 45].
